Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

被引：0
|
作者：
Yong Tae Kim
Min Wook Kang
Joon Kyu Lee
Young Min Lee
Joong Il Kim
机构：
[1] Hallym University Kangnam Sacred Heart Hospital,Department of Orthopaedic Surgery
[2] Hallym University Sacred Heart Hospital,Department of Orthopaedic Surgery
来源：
BMC Musculoskeletal Disorders | / 19卷
关键词：
Total knee replacement; Tranexamic acid; Rivaroxaban; Blood loss; Transfusion; Wound complication; Deep vein thrombosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis
    Kim, Yong Tae
    Kang, Min Wook
    Lee, Joon Kyu
    Lee, Young Min
    Kim, Joong Il
    BMC MUSCULOSKELETAL DISORDERS, 2018, 19
  • [2] Topical Tranexamic Acid Reduces Blood Loss and Transfusion Rates in Total Hip and Total Knee Arthroplasty
    Konig, Gerhardt
    Hamlin, Brian R.
    Waters, Jonathan H.
    JOURNAL OF ARTHROPLASTY, 2013, 28 (09): : 1473 - 1476
  • [3] Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial
    Lu Zhang
    Yanming Li
    Dong Liu
    Xing Xiao
    Tingjin Guan
    Hongwei Yue
    Haipeng Xue
    Hongming Zhou
    Guangjun Jiao
    Wenliang Wu
    Hongliang Wang
    Haichun Liu
    Chunyang Meng
    Zhaozhong Sun
    Yunzhen Chen
    International Orthopaedics, 2020, 44 : 2079 - 2087
  • [4] Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty
    Eric Tille
    Jonas Mysliwietz
    Franziska Beyer
    Anne Postler
    Jörg Lützner
    BMC Musculoskeletal Disorders, 20
  • [5] Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty
    Tille, Eric
    Mysliwietz, Jonas
    Beyer, Franziska
    Postler, Anne
    Luetzner, Joerg
    BMC MUSCULOSKELETAL DISORDERS, 2019, 20 (1)
  • [6] Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial
    Zhang, Lu
    Li, Yanming
    Liu, Dong
    Xiao, Xing
    Guan, Tingjin
    Yue, Hongwei
    Xue, Haipeng
    Zhou, Hongming
    Jiao, Guangjun
    Wu, Wenliang
    Wang, Hongliang
    Liu, Haichun
    Meng, Chunyang
    Sun, Zhaozhong
    Chen, Yunzhen
    INTERNATIONAL ORTHOPAEDICS, 2020, 44 (10) : 2079 - 2087
  • [7] Topical Tranexamic Acid Reduces Transfusion Rates in Total Hip and Knee Arthroplasty
    Gilbody, Julian
    Dhotar, Herman S.
    Perruccio, Anthony V.
    Davey, J. Roderick
    JOURNAL OF ARTHROPLASTY, 2014, 29 (04): : 681 - 684
  • [8] Topical Tranexamic Acid Reduces Blood Loss in Minimally Invasive Total Knee Arthroplasty Receiving Rivaroxaban
    Yen, Shih-Hsiang
    Lin, Po-Chun
    Chen, Bradley
    Huang, Chung-Chen
    Wang, Jun-Wen
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [9] Comment on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial"
    Dong, Haitao
    Lu, Yali
    Luo, Yannian
    INTERNATIONAL ORTHOPAEDICS, 2021, 45 (07) : 1903 - 1904
  • [10] Comment on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial”
    Haitao Dong
    Yali Lu
    Yannian Luo
    International Orthopaedics, 2021, 45 : 1903 - 1904
12345